ChroniSense Medical

Company Overview

Snapshot

Founded in January 2015 by Yossi Gross and Danny Lange, ChroniSense Medical operates with 11–50 employees. The company has secured one funding round from one investor. In December 2022, ChroniSense Medical received FDA 510(k) clearance for its RPM wearable device.

Business overview

ChroniSense Medical develops a wearable medical sensor platform, Polso, designed for accurate, reliable, multiparametric data collection. This technology serves both home and hospital/clinical settings, providing continuous and spot-check patient monitoring. Polso integrates with existing patient status systems like NEWS and aims to enable more flexible non-institutional patient care, thereby reducing healthcare costs. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Digital Healthcare, and Patient Remote Monitoring.

Strategic signal

In December 2022, ChroniSense Medical received FDA 510(k) clearance for its RPM wearable. This regulatory approval is a significant validation for the company's technology, enabling broader market access and commercialization within the remote patient monitoring sector. For investors, this signals a critical de-risking event and a clear path to market entry in the highly regulated medical device industry, positioning ChroniSense for potential growth in digital healthcare.

Company Intelligence Q&A

What is ChroniSense Medical's primary product?

ChroniSense Medical's primary product is Polso, a wearable medical sensor platform that provides accurate, reliable, multiparametric data for chronic disease management.

When was ChroniSense Medical founded?

ChroniSense Medical was founded in January 2015.

Has ChroniSense Medical received any regulatory approvals?

Yes, in December 2022, ChroniSense Medical received FDA 510(k) clearance for its RPM wearable device.

Who are the founders of ChroniSense Medical?

ChroniSense Medical was co-founded by Yossi Gross and Danny Lange.

What was a key leadership change at ChroniSense Medical?

In March 2020, ChroniSense Medical appointed a new CEO, Bridget A. Ross.